Health Care • Medical/Dental Instruments
$412.62 ▼ -4.05
(-0.97%)
MKT CAP: $28.74B • VOL: 1.06M
52W L $224 52W H $438
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$347
MEDIAN
$462
MEAN
$470
HIGH
$561
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE WST TAPE
WST // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $499.27 | $474.51 | 2025-02-14 | $375.48 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $519.90 | $486.89 | 2025-02-06 | $387.86 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $470.39 | $453.88 | 2025-01-29 | $396.12 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $420.87 | — | 2025-01-17 | $404.37 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $363.11 | $391.99 | 2025-01-09 | $367.23 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $491.02 | $429.12 | 2024-12-18 | $358.98 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $400.24 | $416.75 | 2024-12-04 | $383.74 | -4.3% | 48% | C |